Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel inotropic agent EGIS-9377: potential advantages in the treatment of CHF

Dec. 16, 1999

Indian scientists explore mechanism of cardioprotective effect of PAF antagonist

Dec. 15, 1999

Concor COR cleared for marketing in Germany as heart failure treatment

Dec. 15, 1999

Sankyo accelerates antiangina drug development

Dec. 15, 1999

Optimal dose discerned for clinprost in arteriosclerosis obliterans

Dec. 14, 1999

Angiotensin II antagonists with isoquinoline structure discovered at Chinese university

Dec. 14, 1999

Selectus successfully completes phase IIb trial of beta-blocker

Dec. 14, 1999

HU-308: a potent and specific agonist at the peripheral cannabinoid receptor

Dec. 13, 1999

New cardiovascular gene therapy product appears to be safe in patients

Dec. 10, 1999

CV Therapeutics advances CVT-510 into phase II clinical trials

Dec. 10, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...